Search
for
Sort by
Research 211–240 of 409
- Supplementary Material for: GLP-1 Receptor Agonists and Alopecia: A Systematic Review and Meta-analysis of Incidence, Risk, Subtypes, and Mechanisms
- Supplementary Material for: GLP-1 Receptor Agonists and Alopecia: A Systematic Review and Meta-analysis of Incidence, Risk, Subtypes, and Mechanisms
- Real World Evidence in Alopecia Areata: Current Management, Emerging Therapies and Future Challenges – A Narrative Review
- The Role of Glucagon-Like Peptide-1 Receptor Agonists in Hair Loss: Clinical Evidence and Proposed Mechanisms
- Persistent Sexual and Psychological Symptoms After Finasteride Discontinuation: A Cross-Sectional Observational Study
- Cardiovascular Safety Signals of Oral Versus Topical Minoxidil in FAERS: A Disproportionality Analysis (Analytic Cohort 2012–2025)
- Impact of Reporter Type on Signal Detection of Cancer Therapy-Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System
- ORAL AND TOPICAL FINASTERIDE IN THE TREATMENT OF MALE ANDROGENETIC ALOPECIA – NARRATIVE REVIEW
- Cosmetovigilance studies to assess the safety of cosmetic therapy in hair segments and skin non-laser
- 5α-Reductase Isoenzymes: From Neurosteroid Biosynthesis to Neuropsychiatric Outcomes
- ADVERSE EFFECTS OF RITLECITINIB IN ADULTS AND ADOLESCENTS WITH ALOPECIA AREATA: A LITERATURE REVIEW
- Understanding the safety profile of topical minoxidil: a retrospective review
- Reframing the Discussion on Finasteride and Neuropsychiatric Safety
- Application of big data analytics in minoxidil drug development: a data-driven model for predicting efficacy and side effect risks
- Testosterone Pellets in Women: Revisiting Safety and Clinical Outcomes
- Randomized Control Clinical Trial to assess the combine effect of Bhringaraja Taila Shiroabhyanga and Yastimadhuka Taila Nasya in Khalitya of Females
- Alopecia as an Emerging Adverse Effect Associated With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists for Weight Loss: A Scoping Review
- Spotlight commentary: Navigating the cutaneous side effects of chemotherapy
- Association between finasteride with subjective memory deficits: a study from the NHANES and FAERS databases
- Xerostomia as a rare adverse effect of low-dose oral minoxidil: a case report with recurrence after re-challenge
- Exploring the hair loss risk in glucagon‐like peptide‐1 agonists: Emerging concerns and clinical implications
- Alopecia universalis following human papillomavirus vaccine administration: a case report
- The Role of Patient‐ and Drug‐Related Factors in Oral Minoxidil and Pericardial Effusion: Analyses of Data From the United States Food and Drug Administration Adverse Event Reporting System
- Safety concerns of paternal drug exposure on fertility, pregnancy and offspring: An analysis based on the FDA adverse event reporting system
- Low‐Dose Oral Minoxidil and Associated Adverse Events: Analyses of the FDA Adverse Event Reporting System (FAERS) With a Focus on Pericardial Effusions
- Cyclosporine-induced alopecia:a case report, FDA adverse event reporting system analysis and literature assessment
- 272 Dupilumab treatment in children with alopecia areata: A real-world, single-center observational study
- Quantitative and qualitative analysis of individual experiences post botulinum toxin injection ‐ United Kingdom Survey
- A proposed etiopathology of persistent dysfunctions emerging from use and discontinuation of 5-alpha reductase inhibitors: sequelae of drug-mediated microvasculopathy
- Hair and Aging.